On 24 July 2025, Lanxess Deutschland GmbH submitted to the European Chemicals Agency (‘the Agency’), in accordance with Article 12(1) of Implementing Regulation (EU) No 354/2013, an application for minor changes to the Union authorisation for the biocidal product family ‘LANXESS CMIT/MIT biocidal product family’, as referred to in Title 2 of the Annex to that Regulation. The application was recorded in the Register for Biocidal Products under case number BC-HT109132-36. The proposed changes to that authorisation concern the extension of the shelf life of products in meta-SPC 1 to 6.
Recital 3, Regulation (EU) 2026/2024
In forcesince 10 Sep 2026